Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
N Engl J Med
.
2023 Jan 19;388(3):283.
doi: 10.1056/NEJMc2215181.
Authors
Joséphine C Janssen
1
,
Evalyn E A P Mulder
1
,
Astrid A M van der Veldt
1
Affiliation
1
Erasmus Medical Center, Rotterdam, the Netherlands j.c.janssen@erasmusmc.nl.
PMID:
36652364
DOI:
10.1056/NEJMc2215181
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Hypopigmentation*
Nitriles
Pyrimidines
Vitiligo* / drug therapy
Substances
ruxolitinib
Nitriles
Pyrimidines